ManifestSeven Holdings Corporation
ManifestSeven Holdings Corporation
Your view on MNFSF
Overview
What the company does, where it operates, and who runs it.
About ManifestSeven Holdings Corporation
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Sturges J. Karban
- Headquarters
- 111 Pacifica, Irvine, CA, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Sturges J. Karban
- Headquarters
- 111 Pacifica, Irvine, CA, US
ManifestSeven Holdings Corporation operates an integrated omnichannel platform for legal cannabis. It operates through three segments M7 Regulated, Inc.; M7 Unregulated, Inc.; and M7 Solutions, LLC. The company operates industrial warehouse and retail storefront facilities for cannabis distribution, delivery, and dispensary operations.
It also wholesales, distributes, and retails ancillary products to licensed cannabis operators and ancillary operators. In addition, the company provides financial services, and capital hub and non-financial services related to building and owning brands and intellectual property.
Further, it offers commercial and compliant services to licensed cannabis cultivators, manufacturers, distributors, and retailers. ManifestSeven Holdings Corporation is headquartered in Irvine, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for ManifestSeven Holdings Corporation, and the rating behind it. MNFSF last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for ManifestSeven Holdings Corporation. Starting points for ManifestSeven Holdings Corporation: EPS -$0.78, beta -0.13 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for ManifestSeven Holdings Corporation. ManifestSeven Holdings Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for ManifestSeven Holdings Corporation. Trailing twelve-month EPS for ManifestSeven Holdings Corporation stands at -$0.78. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for ManifestSeven Holdings Corporation. ManifestSeven Holdings Corporation has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
ManifestSeven Holdings Corporation valued side by side against its closest peers. ManifestSeven Holdings Corporation is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold ManifestSeven Holdings Corporation, and how their positions are changing. At a $1,707 market value, institutional positions materially move ManifestSeven Holdings Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by ManifestSeven Holdings Corporation executives and directors. Shares of ManifestSeven Holdings Corporation have traded between $0.0000 and $0.0000 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming ManifestSeven Holdings Corporation. ManifestSeven Holdings Corporation is a $1,707 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming ManifestSeven Holdings Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for ManifestSeven Holdings Corporation. Coverage tracks ManifestSeven Holdings Corporation within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.